Showing results (171-180 of 245) with videos related to
Sort By:
Pageof 25
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancerHong Song, Maria Isabel Leonio, Valentina Ferri, et al.Clinical Genitourinary Cancer|May 3, 2014
First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database ConsortiumLauren C Harshman, Nils Kroeger, Sun Young Rha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisoneCharles J Ryan, Mark Rosenthal, Siobhan Ng, et al.Annals of Intensive Care|May 12, 2024
Pulmonary redox imbalance drives early fibroproliferative response in moderate/severe coronavirus disease-19 acute respiratory distress syndrome and impacts long-term lung abnormalitiesChun Yang, Yuanyuan Tan, Zihao Li, et al.Database : the Journal of Biological Databases and Curation|January 18, 2023
ENCD: a manually curated database of experimentally supported endocrine system disease and lncRNA associationsMing Hao, Yue Qi, Rongji Xu, et al.Journal of Reproductive Immunology|April 5, 2025
Measurement of four novel endometrial NK cell subsets by multiplex staining in women with reproductive failure: A comparison with fertile controlsLu Chen, Wen-Jui Yang, Xiaoyan Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial CancerChristopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and CrizotinibAbhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, et al.Future Oncology (London, England)|November 23, 2023
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumabChristopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 7, 2022
Serial changes in two immune checkpoint receptors and ligands, Tim-3/Gal-9 and PD-1/PD-L1 in peripheral blood prior to miscarriage: Comparison with pregnancies resulting in a live birthTao Zhang, Yiwei Zhao, Wing Ching Cheung, et al.Pageof 25